Search Results - Xinyi Sun

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    A real-world study of palbociclib plus endocrine therapy with or without a short course chemotherapy in the first-line treatment of HR-positive HER2-negative metastatic breast cancer

    A real-world study of palbociclib plus endocrine therapy with or without a short course chemotherapy in the first-line treatment of HR-positive HER2-negative metastatic breast canc... by Xiangjun Li, Yuhua Song, Meng Lv, Yongmei Wang, Xueqiang Gao, Tianyi Ma, Teng Ma, Changgen Liu, Xinyi Sun, Haibo Wang, Yan Mao

    Published 2025-07-01

    BackgroundTo investigate the efficacy of palbociclib plus endocrine therapy (ET) as the initial treatment compared with post-chemotherapy maintenance therapy in the first-line treatment of hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative) meta...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: